GS1 Standard Would Speed The Sale Of Returned Drugs After November Deadline

 
• By Joanne S. Eglovitch
  
Verification
GS1 Official Says New Guideline Should Help Manufacturers Process Salable Returns Quickly • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Distribution/Supply Chain

More from Compliance